Skip to main content
SpringerLink
Log in

Immunocytochemical detection of DNA topoisomerase type II in primary breast carcinomas: Correlation with clinico-pathological features

  • Original Articles
  • Published:
Virchows Archiv A Aims and scope Submit manuscript

Abstract

DNA topoisomerase type II (DT-II) is a major component of interphase nuclear matrix fractions, present in S-phase of the cell cycle. A series of 80 carcinomatous breast surgical samples was evaluated by immunohistochemistry, using a polyclonal antibody in a comparison with Ki-67 antiserum. A correlation with clinico-pathological data was also performed. Infiltrating ductal and lobular carcinomas constantly express DT-II with varying intensity of nuclear staining; a similar immunohistochemical pattern is observed with Ki-67. A frequent co-expression of DT-II and Ki-67 is encountered with double immunostaining; accordingly to these data, a linear relationship is evident when linear regression is employed. In addition, significant relationships between DT-II values and tumour size, histological grade and node involvement are shown, while an inverse correlation is appreciable between DT-II and oestrogen receptors and progesterone receptors. DT-II may be considered to be an additional operational marker for the proliferating fraction of cells in breast carcinomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Barnard NJ, Hall PA, Lemoine NR, Kadar N (1987) Proliferative index in breast carcinoma determined in situ by Ki-67 immunostaining and its relationship to clinical and pathological variables. J Pathol 152:287–295

    Google Scholar 

  • Berrios M, Osheroff N, Fisher PA (1985) In situ localization of DNA topoisomerase II, a major polypeptide component of theDrosophila nuclear matrix fraction. Proc Natl Acad Sci USA 82:4142–4146

    Google Scholar 

  • Bloom HJG, Richardson WW (1957) Histological grading and prognosis in breast cancer. Br J Cancer 11:359–377

    Google Scholar 

  • Bodley AL, Wu HY, Liu LF (1987) Regulation of DNA topoisomerases during cellular differentiation. Monogr Natl Cancer Inst 4:31–35

    Google Scholar 

  • Bouzubar N, Walker KJ, Griffiths K (1989) Ki-67 immunostaining in primary breast cancer: pathological clinical associations. Br J Cancer 59:943–947

    Google Scholar 

  • Chow KC, Ross WE (1987) Topoisomerase-specific drug sensitivity in relation to cell cycle progression. Mol Cell Biol 7:3119–3123

    Google Scholar 

  • Duguet M, Lavenot C, Harper H, Mirambeau G, De Recondo AM (1983) DNA topoisomerases from rat liver: physiological variations. Nucleic Acids Res 11:1059–1075

    Google Scholar 

  • Epstein RJ, Smith PJ, Watson JV, Waters C, Bleehen NM (1989) Oestrogen potentiates topoisomerase II mediated cytotoxicity in an activated subpopulation of human breast cancer cells: implications for cytotoxic drug resistance in solid tumours. Int J Cancer 44:501–505

    Google Scholar 

  • Fonatsch C, Duchrow M, Rieder H (1991) Assignment of the human Ki-67 gene (MK 167) to 10q25-qter. Genomics 11:476–477

    Google Scholar 

  • Gerdes J, Lelle RJ, Pickartz H (1986) Growth fraction in breast cancers determined in situ with monoclonal antibody Ki-67. J Clin Pathol 39:977–980

    Google Scholar 

  • Gerdes J, Pickartz H, Brotherton J, Hammerstein J, Weitzel H, Stein H (1987) Growth fractions and estrogen receptors in human breast cancers as determined in situ with monoclonal antibodies. Am J Pathol 129:486–492

    Google Scholar 

  • Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C, Stahmer I, Kloth S, Brandt E, Flad HD (1991) Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 138:867–873

    Google Scholar 

  • Hall PA, Levison DA (1990) Assessment of cell proliferation in histological material. J Clin Pathol 43:184–192

    Google Scholar 

  • Hall PA, Woods AL (1990) Immunohistological markers of cell proliferation: achievements, problems and prospects. Cell Tissue Kinet 23:531–549

    Google Scholar 

  • Harland RM, Weintraub H, McKnight SL (1983) Transcription of DNA injected intoXenopus oocytes is influenced by template topology. Nature 302:38–43

    Google Scholar 

  • Heck MMS, Earnshaw WC (1986) Topoisomerase II: a specific marker for cell proliferation. J Cell Biol 103:2569–2581

    Google Scholar 

  • Hsiang Y, Wu HY, Liu LF (1988) Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells. Cancer Res 48:3230–3235

    Google Scholar 

  • Kaguni JM, Kornberg A (1984) Replication initiated at the origin (ori C) of theE. coli chromosome reconstituted with purified enzymes. Cell 38:183–190

    Google Scholar 

  • Lelle' RJ, Heidenreich W, Stauch G, Gerdes J (1987) The correlation of growth fraction with histologic grading and lymph node status in human mammary carcinoma. Cancer 59:83–88

    Google Scholar 

  • Liu LF (1983) DNA topoisomerases: enzymes that catalyse the breaking and rejoining of DNA. CRC Crit Rev Biochem 15:1–24

    Google Scholar 

  • Liu LF (1989) DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem 58:351–375

    Google Scholar 

  • Luchnik AN, Bakayev VV, Zbarsky IB, Georgief GP (1982) Elastic torsional strain in DNA within a fraction of SV40 minichromosomes: relation to transcriptionally active chromatin. EM-BO J 1:1353–1358

    Google Scholar 

  • Marchetti E, Querzoli P, Marzola A, Bagni A, Ferretti S, Fabris G, Nenci I (1990) Assessment of proliferative rate of breast cancer by Ki-67 monoclonal antibody. Mod Pathol 3:31–35

    Google Scholar 

  • Mason DY, Sammons R (1978) Alkaline phosphatase and peroxidase for double immunoenzymatic labelling of cellular constituents. J Clin Pathol 31:454–460

    Google Scholar 

  • Nelson EM, Tewey KM, Liu LF (1984) Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4′-(9-acridinylamino)-methanesulfon-m-amsidine. Proc Natl Acad Sci USA 81:1361–1365

    Google Scholar 

  • Potmesil M (1988) DNA topoisomerase II as intracellular target in anthracycline treatment of cancer. In: Lown JW (ed) Anthracyclines and anthracenedione-based anticancer agents. Elsevier New York.

    Google Scholar 

  • Potmesil M, Hsiang YH, Liu LF, Bank B, Grossberg H, Kirschenbaum S, Forlenzar T, Penziner A, Kanganis D, Knowles D, Traganos F, Silber R (1988) Resistance of human leukemic and normal lymphocytes to drug-induced DNA cleavage and low levels of DNA topoisomerase II. Cancer Res 48:3537–3543

    Google Scholar 

  • Raymond WA, Leong AS-Y (1989) The relationship between growth fractions and oestrogen receptors in human breast carcinoma, as determined by immunohistochemical staining. J Pathol 158:203–211

    Google Scholar 

  • Smith PJ, Makinson TA (1989) Cellular consequences of overproduction of DNA topoisomerase II in an ataxia-telangiectasia cell line. Cancer Res 49:1118–1124

    Google Scholar 

  • Sullivan DM, Glisson BS, Hodges PK, Smallwood-Kentro S, Ross WE (1986) Proliferation dependence of topoisomerase II mediated drug action. Biochemistry 25:2248–2256

    Google Scholar 

  • Tan KB, Dorman TE, Falls KM, Chung TDY, Mirabelli CK, Crooke ST, Mao J (1992) Topoisomerase II alfa and topoisomerase II beta genes: characterization and mapping to human chromosomes 17 and 3, respectively. Cancer Res 53:231–234

    Google Scholar 

  • Tandon AK, Hilsenbeck SG, Clark GM, Allred DC, Latham MD, Ross WE, McGuire WL (1991) Significance of topoisomerase II in clinical breast cancer. Proc Am Assoc Cancer Res 32:350

    Google Scholar 

  • Tandou G, Mirambeau G, Lavenot G, Garabedian A der, Vermeersch J, Duguet M (1984) DNA topoisomerase activities in concanavalin A-stimulated lymphocytes. FEBS Lett 176:431–435

    Google Scholar 

  • Tewey KM, Rowe TC, Yang L, Halligan BD, Liu LF (1983) Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science 226:466–468

    Google Scholar 

  • Tricoli JV, Sahai BM, McCormick PJ, Sarlinski SJ, Bertram JS, Kowalski D (1985) DNA topoisomerase I and II activities during cell proliferation and the cell cycle in cultured mouse embryo fibroblast (C3H10T1/2) cells. Exp Cell Res 158:1–14

    Google Scholar 

  • Verheijen R, Kuijpers HJH, Van Driel R (1989) Ki-67 detects a nuclear matrix-associated proliferation-related antigen. II. Localization in mitotic cells and association with chromosomes. J Cell Sci 92:531–540

    Google Scholar 

  • Wang JC (1985) DNA topoisomerases. Annu Rev Biochem 54:665–697

    Google Scholar 

  • Wrba F, Reiner A, Markis-Ritzinger E, Holzner JH, Reiner G, Spona J (1988) Prognostic significance of immunohistochemical parameters in breast carcinomas. Pathol Res Pract 183:277–283

    Google Scholar 

  • Yang L, Rowe TC, Liu LF (1985) Identification of DNA topoisomerase II as an intracellular target of antitumor epipodophyllotoxins in Simian Virus 40-infected monkey cells. Cancer Res 45:5872–5876

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Human Pathology, University of Messina, Messina, Italy

    G. Tuccari, A. Rizzo, G. Giuffre' & G. Barresi

Authors
  1. G. Tuccari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Rizzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Giuffre'
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Barresi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tuccari, G., Rizzo, A., Giuffre', G. et al. Immunocytochemical detection of DNA topoisomerase type II in primary breast carcinomas: Correlation with clinico-pathological features. Vichows Archiv A Pathol Anat 423, 51–55 (1993). https://doi.org/10.1007/BF01606432

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01606432

Key words

Search

Navigation